pI: 4.6332 |
Length (AA): 280 |
MW (Da): 33196 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 9 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
20 | 153 | 1k5d (B) | 27 | 163 | 51.00 | 0 | 1 | 1.03 | -0.21 |
33 | 155 | 1xke (A) | 2 | 124 | 42.00 | 0 | 1 | 0.79 | -0.33 |
17 | 153 | 5cll (B) | 15 | 152 | 50.00 | 0 | 1 | 1.07959 | -0.59 |
17 | 155 | 1k5d (B) | 24 | 165 | 46.00 | 0 | 1 | 0.977729 | 0 |
33 | 155 | 4l6e (A) | 2925 | 3047 | 42.00 | 0 | 1 | 0.984286 | -0.87 |
33 | 155 | 1xke (A) | 2 | 124 | 43.00 | 0 | 1 | 0.908286 | -0.01 |
116 | 263 | 4uos (A) | 27 | 176 | 26.00 | 0.086 | 0.32 | 1.02257 | -2.54 |
163 | 222 | 3k29 (A) | 90 | 149 | 33.00 | 0.14 | 0.02 | 0.996286 | -4.62 |
189 | 277 | 3qrx (A) | 63 | 161 | 31.00 | 0.88 | 0.05 | 0.759857 | -2.49 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | intra-erythrocytic - 48 hs, gametocyte, merozoite, sporozoite, early ring, early schizont, early trophozoite, late ring, late schizont, late trophozoite, Oocyst, Ring, Female Gametocyte, Male Gametocyte. | Otto TD PlasmoDB Zanghi G Lasonder E |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | intra-erythrocytic - 0 hs, intra-erythrocytic - 8 hs, intra-erythrocytic - 16 hs, intra-erythrocytic - 24 hs, intra-erythrocytic - 32 hs, intra-erythrocytic - 40 hs, Sporozoite. | Otto TD Zanghi G |
PlasmoDB | Data on upregulation of P. falciparum genes in different life cycle stages, combined from several microarray experiments available in PlasmoDB |
Zanghi G | A Specific PfEMP1 Is Expressed in P. falciparum Sporozoites and Plays a Role in Hepatocyte Infection. |
Lasonder E | Integrated transcriptomic and proteomic analyses of P. falciparum gametocytes. Molecular insight into sex-specific processes and translational repression. |
Otto TD | New insights into the blood-stage transcriptome of Plasmodium falciparum using RNA-Seq. |
Ortholog group members (OG5_127714)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G58590 | Ran-binding protein 1 |
Arabidopsis thaliana | AT1G07140 | Ran-binding protein 1-a |
Arabidopsis thaliana | AT2G30060 | Ran-binding protein 1-b |
Babesia bovis | BBOV_II004260 | ran binding-like protein 1 |
Brugia malayi | Bm1_09710 | RanBP1 domain containing protein |
Candida albicans | CaO19.7477 | similar to S. cerevisiae YRB1 (YDR002W) RanGTP binding protein |
Caenorhabditis elegans | CELE_F59A2.1 | Protein NPP-9, isoform A |
Cryptosporidium hominis | Chro.50456 | Ran-binding protein |
Cryptosporidium parvum | cgd5_3950 | Ran-binding protein |
Dictyostelium discoideum | DDB_G0287391 | Ran binding protein 1 domain-containing protein |
Echinococcus granulosus | EgrG_000906500 | E3 SUMO protein ligase RanBP2 |
Echinococcus granulosus | EgrG_001100900 | Ran specific GTPase activating protein |
Entamoeba histolytica | EHI_185290 | Ran GTPase-activating protein, putative |
Echinococcus multilocularis | EmuJ_001100900 | Ran specific GTPase activating protein |
Giardia lamblia | GL50803_16969 | RAN binding protein 1 |
Homo sapiens | ENSG00000099901 | RAN binding protein 1 |
Leishmania braziliensis | LbrM.13.1240 | Ran-binding protein 1, putative |
Leishmania donovani | LdBPK_131530.1 | Ran-binding protein 1, putative |
Leishmania infantum | LinJ.13.1530 | Ran-binding protein 1, putative |
Leishmania major | LmjF.13.1480 | Ran-binding protein 1, putative |
Leishmania mexicana | LmxM.13.1480 | Ran-binding protein 1, putative |
Loa Loa (eye worm) | LOAG_04279 | hypothetical protein |
Loa Loa (eye worm) | LOAG_13273 | hypothetical protein |
Mus musculus | 19385 | RAN binding protein 1 |
Neospora caninum | NCLIV_000280 | RanBP1 domain containing protein, related |
Oryza sativa | 4332513 | Os03g0292800 |
Oryza sativa | 4338501 | Os05g0350600 |
Plasmodium berghei | PBANKA_0721700 | ran-specific GTPase-activating protein 1, putative |
Plasmodium falciparum | PF3D7_0419600 | ran-specific GTPase-activating protein 1, putative |
Plasmodium knowlesi | PKNH_0512300 | ran-specific GTPase-activating protein 1, putative |
Plasmodium vivax | PVX_090070 | ran binding protein 1, putative |
Plasmodium yoelii | PY07276 | Ran-binding protein |
Saccharomyces cerevisiae | YDR002W | Yrb1p |
Schistosoma japonicum | Sjp_0077690 | Ran-specific GTPase-activating protein, putative |
Schistosoma japonicum | Sjp_0088510 | E3 SUMO-protein ligase RanBP2, putative |
Schistosoma japonicum | Sjp_0086550 | expressed protein |
Schistosoma mansoni | Smp_016410 | ran-binding protein |
Schmidtea mediterranea | mk4.006294.06 | |
Schmidtea mediterranea | mk4.000167.18 | |
Trypanosoma brucei gambiense | Tbg972.11.3820 | Ran-binding protein 1, putative |
Trypanosoma brucei | Tb927.11.3380 | Ran-binding protein 1, putative |
Trypanosoma congolense | TcIL3000.11.3270 | Ran-binding protein 1, putative |
Trypanosoma cruzi | TcCLB.507099.30 | Ran-binding protein 1, putative |
Toxoplasma gondii | TGME49_293340 | ran binding family protein 1, putative |
Theileria parva | TP04_0179 | ran binding protein, putative |
Trichomonas vaginalis | TVAG_337260 | ran-binding protein, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb11.02.0870 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb11.02.0870 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb11.02.0870 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb11.02.0870 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_F59A2.1 | Caenorhabditis elegans | embryonic lethal | wormbase |
YDR002W | Saccharomyces cerevisiae | inviable | yeastgenome |
TGME49_293340 | Toxoplasma gondii | Probably essential | sidik |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.